Oxford GlycoSciences and Pfizer extend collaboration

Oxford GlycoSciences (OGSI; LSE:OGS) and PFE will continue their 1998 collaboration to use OGSI's proteomics technology to discover biomarkers and drug targets for Alzheimer's disease and atherosclero...